🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Halis Kaan Aktürk

University of Colorado Anschutz Medical Campus

ORCID: 0000-0003-4518-5179

Also affiliated with University of Colorado Denver

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards”.

Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards

Diabetes Care(2021)10.2337/dc20-3063
N/A
0.661DataRank · unranked
81 citations

Shivani Agarwal, Lilian Hoffecker, Viral N. Shah, Halis Kaan Aktürk

Increasing Use of Diabetes Devices: What Do Health Care Professionals Need?

Clinical Diabetes(2023)10.2337/cd22-0092
N/A
0.625DataRank · unranked
9 citations

Tim Vigers, Halis Kaan Aktürk, Gregory P. Forlenza, Kelsey B. Huss, ANGELA J. KARAMI +8 more

Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System

Journal of Diabetes Science and Technology(2024)10.1177/19322968241291512
N/A
0.515DataRank · unranked
30 citations

Anne L. Peters, Guillermo E. Umpierrez, Jennifer L. Sherr, Halis Kaan Aktürk, Grazia Aleppo +18 more

Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis

Diabetes Metabolic Syndrome and Obesity(2023)10.2147/dmso.s416192
N/A
0.489DataRank · unranked
25 citations

Andrea Gerard Gonzalez, Viral N. Shah, Cristy Geno Rasmussen, Halis Kaan Aktürk, Laura Pyle +4 more

Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes

Diabetes Technology & Therapeutics(2024)10.1089/dia.2023.0476
N/A
0.385DataRank · unranked
12 citations

Halis Kaan Aktürk

Retained Diabetes Devices—A Literature Review

Journal of Diabetes Science and Technology(2022)10.1177/19322968221105895
N/A
0.104DataRank · unranked
1 citations

Kevin T. Nguyen, Jan S. Krouwer, Halis Kaan Aktürk, Viral N. Shah, David C. Klonoff +1 more

Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial

Nature Medicine(2022)10.1038/s41591-022-02011-x
N/A
0DataRank · unranked
57 citations

Schafer Boeder, Mark P. Christiansen, Douglas Denham, Timothy S. Bailey, Halis Kaan Aktürk +11 more

Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers with Varying Levels of Baseline Glycemic Control

Diabetes Technology & Therapeutics(2024)10.1089/dia.2024.0501
N/A
0DataRank · unranked
5 citations

Lori M. Laffel, Halis Kaan Aktürk, Gregory P. Forlenza, Viral N. Shah, R. Paul Wadwa +10 more

Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population

Diabetes Care(2023)10.2337/dc22-2121
N/A
0DataRank · unranked
28 citations

Taylor M. Triolo, Halis Kaan Aktürk, MEGHAN E. PAULEY, Marisa Sobczak, Gregory P. Forlenza +4 more

Analysis of Human Leukocyte Antigen DR Alleles, Immune-Related Adverse Events, and Survival Associated With Immune Checkpoint Inhibitor Use Among Patients With Advanced Malignant Melanoma

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.46400
N/A
0DataRank · unranked
33 citations

Kasey L. Couts, Erin E. Baschal, Kagan E. Karakus, Robert J. Van Gulick, Jacqueline A. Turner +4 more